The global bone marrow industry, primarily encompassing products and services related to diagnostics, procurement, and transplantation, is experiencing robust growth fueled by the increasing worldwide incidence of hematological malignancies suchments as leukemia and lymphoma. The market, which was valued at USD 11.11 billion in 2024, is projected to maintain a Compound Annual Growth...